Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Adnan Naguez"'
Autor:
Thibault Passeri, Ahmed Dahmani, Julien Masliah-Planchon, Adnan Naguez, Marine Michou, Rania El Botty, Sophie Vacher, Rachida Bouarich, André Nicolas, Marc Polivka, Coralie Franck, Anne Schnitzler, Fariba Némati, Sergio Roman-Roman, Franck Bourdeaut, Homa Adle-Biassette, Hamid Mammar, Sébastien Froelich, Ivan Bièche, Didier Decaudin
Publikováno v:
Cancers, Vol 14, Iss 6, p 1486 (2022)
Chordomas are rare neoplasms characterized by a high recurrence rate and a poor long-term prognosis. Considering their chemo-/radio-resistance, alternative treatment strategies are strongly required, but their development is limited by the paucity of
Externí odkaz:
https://doaj.org/article/a67713347fb849e7a4912cb619b47179
Autor:
Leanne de Koning, Didier Decaudin, Rania El Botty, André Nicolas, Guillaume Carita, Mathieu Schuller, Bérengère Ouine, Aurélie Cartier, Adnan Naguez, Justine Fleury, Vesselina Cooke, Andrew Wylie, Paul Smith, Elisabetta Marangoni, David Gentien, Didier Meseure, Pascale Mariani, Nathalie Cassoux, Sophie Piperno-Neumann, Sergio Roman-Roman, Fariba Némati
Publikováno v:
Cancers, Vol 11, Iss 6, p 751 (2019)
Uveal melanoma (UM) remains without effective therapy at the metastatic stage, which is associated with BAP-1 (BRCA1 associated protein) mutations. However, no data on DNA repair capacities in UM are available. Here, we use UM patient-derived xenogra
Externí odkaz:
https://doaj.org/article/bcff6918d5834b8c96d4af95c03c16cc
Autor:
Didier Decaudin, Estelle Frisch Dit Leitz, Fariba Nemati, Malcy Tarin, Adnan Naguez, Mohamed Zerara, Benjamin Marande, Raquel Vivet-Noguer, Ensar Halilovic, Claire Fabre, Aart Jochemsen, Sergio Roman-Roman, Samar Alsafadi
Publikováno v:
European Journal of Cancer. 184:199
Autor:
Leila Zemoura, Damien Treguer, Nicolas Girard, Marie Brevet, A. Chapelier, Didier Decaudin, Olivier Deas, Sophie Chateau-Joubert, Stefano Cairo, Rania El Botty, Sergio Roman-Roman, André Nicolas, Didier Meseure, Ivan Bièche, Sophie Vacher, Ludmilla de Plater, Elodie Montaudon, Elisabetta Marangoni, Catherine Daniel, Fariba Nemati, Adnan Naguez, Alain Livartowski
Publikováno v:
Oncotarget. 12:859-872
Significant rational is available for specific targeting of PI3K/AKT/mTOR pathway in the treatment of non-small cell lung cancer (NSCLC). However, almost all clinical trials that have evaluated Pi3K pathway-based monotherapies/combinations did not ob
Autor:
Sergio Roman-Roman, Samar Alsafadi, Benjamin Marande, Didier Decaudin, Adnan Naguez, Raquel Vivet-Noguer, Claire Fabre, Mohamed Zerara, Ensar Halilovic, Aart G. Jochemsen, Fariba Nemati, Estelle Frisch Dit Leitz, Malcy Tarin
Publikováno v:
European Journal of Cancer
European Journal of Cancer, Elsevier, 2020, 126, pp.93-103. ⟨10.1016/j.ejca.2019.12.012⟩
European Journal of Cancer, 126, 93-103. ELSEVIER SCI LTD
European Journal of Cancer, Elsevier, 2020, 126, pp.93-103. ⟨10.1016/j.ejca.2019.12.012⟩
European Journal of Cancer, 126, 93-103. ELSEVIER SCI LTD
Introduction: Uveal melanoma (UM) is a rare and malignant intraocular tumour with a dismal prognosis. Despite a good control of the primary tumour by radiation or surgery, up to 50% of patients subsequently develop metastasis for which no efficient t
Autor:
Thibault Passeri, Ahmed Dahmani, Julien Masliah-Planchon, Adnan Naguez, Marine Michou, Rania El-Botty, Sophie Vacher, Rachida Bouarich, André Nicolas, Marc Polivka, Coralie Franck, Anne Schnitzler, Fariba Némati, Sergio Roman-Roman, Franck Bourdeaut, Homa Adle-Biassette, Hamid Mammar, Sébastien Froelich, Ivan Bièche, Didier Decaudin
Publikováno v:
Cancer Research. 82:LB567-LB567
Background: Chordomas are considered as rare bone neoplasms characterized by a high level of recurrence and a poor long-term prognosis. Considering their chemo-radio-resistance, alternative treatment strategies are therefore strongly requested, but t
Autor:
Elodie, Montaudon, Rania, El Botty, Sophie, Vacher, Olivier, Déas, Adnan, Naguez, Sophie, Chateau-Joubert, Damien, Treguer, Ludmilla, de Plater, Leïla, Zemoura, Fariba, Némati, André, Nicolas, Alain, Chapelier, Alain, Livartowski, Stefano, Cairo, Catherine, Daniel, Marie, Brevet, Elisabetta, Marangoni, Didier, Meseure, Sergio, Roman-Roman, Ivan, Bieche, Nicolas, Girard, Didier, Decaudin
Publikováno v:
Oncotarget
Significant rational is available for specific targeting of PI3K/AKT/mTOR pathway in the treatment of non-small cell lung cancer (NSCLC). However, almost all clinical trials that have evaluated Pi3K pathway-based monotherapies/combinations did not ob
Autor:
Leanne De Koning, Thibaut Larcher, Bérengère Ouine, Ivan Bièche, Rania El Botty, Anne Vincent Salomon, Ahmed Dahmani, Florence Coussy, Jean Marc Guinebretière, Walid Chemlali, Adrien Briaux, Sophie Chateau-Joubert, Marion Lavigne, Sophie Vacher, Samia Melaabi, Guillaume Bataillon, Adnan Naguez, Elodie Montaudon, Elisabetta Marangoni, Pierre Painsec, Fuhrmann Laetitia, Fariba Nemati
Publikováno v:
Theranostics
Theranostics, Ivyspring International Publisher, 2020, 10 (4), pp.1531-1543. ⟨10.7150/thno.36182⟩
Theranostics 4 (10), 1531-1543. (2020)
Theranostics, Ivyspring International Publisher, 2020, 10 (4), pp.1531-1543. ⟨10.7150/thno.36182⟩
Theranostics 4 (10), 1531-1543. (2020)
Luminal androgen receptor (LAR) breast cancer accounts for 10% of all triple-negative breast cancers (TNBC). Anti-androgen therapy for this subtype is in development, but yields only partial clinical benefits. In this study, we aimed to characterize
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::930795e108e4477f2daa3b7b8dacc2a0
https://hal.archives-ouvertes.fr/hal-02509541/document
https://hal.archives-ouvertes.fr/hal-02509541/document
Autor:
Nathalie Cassoux, Rania El Botty, Joanne Wilson, Emma J. Davies, Béré Diallo, Gérald Massonnet, Colin Howes, Adnan Naguez, Chloé Raymondie, Aaron Smith, Sophie Piperno-Neumann, Sergio Roman-Roman, Paul D. Smith, Fariba Nemati, Justine Fleury, Didier Decaudin
Publikováno v:
Oncotarget
The prognosis of metastatic uveal melanoma (UM) is among the worst of all human cancers. The identification of near-ubiquitous GNAQ/GNA11 mutations and the activation of MAPK signaling in UM have raised hopes of more effective, targeted therapies, ba
Autor:
Pascale Mariani, André Nicolas, Leanne De Koning, Aurélie Cartier, Vesselina G. Cooke, Sergio Roman-Roman, Andrew Wylie, Didier Decaudin, Rania El Botty, Adnan Naguez, Fariba Nemati, Nathalie Cassoux, Justine Fleury, Didier Meseure, Guillaume Carita, Paul Smith, Sophie Piperno-Neumann, Elisabetta Marangoni, Mathieu Schuller, David Gentien, Bérengère Ouine
Publikováno v:
Cancers
Volume 11
Issue 6
Cancers, Vol 11, Iss 6, p 751 (2019)
Volume 11
Issue 6
Cancers, Vol 11, Iss 6, p 751 (2019)
Uveal melanoma (UM) remains without effective therapy at the metastatic stage, which is associated with BAP-1 (BRCA1 associated protein) mutations. However, no data on DNA repair capacities in UM are available. Here, we use UM patient-derived xenogra